{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:00:58Z","timestamp":1779145258542,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.06.060","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T07:24:00Z","timestamp":1656746640000},"page":"4816-4826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9\u201318\u00a0years: A time-varying cohort study"],"prefix":"10.1016","volume":"40","author":[{"given":"Bel\u00e9n","family":"Castillo-Cano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Mart\u00edn-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Llorente-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Montero-Corominas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Comas-Cuf\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Mart\u00edn-Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2022.06.060_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49540-z","article-title":"Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the Community","volume":"9","author":"Diab","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2022.06.060_b0010","doi-asserted-by":"crossref","unstructured":"Luster M., Duntas L.H., Wartofsky L., editors. The Thyroid and Its Diseases [Internet]. Cham: Springer International Publishing. 2019 [cited 2021 Apr 28]. Available from: https:\/\/doi.org\/10.1007\/978-3-319-72102-6_6.","DOI":"10.1007\/978-3-319-72102-6"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.060_b0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5455\/msm.2019.31.130-134","article-title":"Annual Incidence of Thyroid Disease in Patients Who First Time Visit Department for Thyroid Diseases in Tuzla Canton","volume":"31","author":"Sulejmanovic","year":"2019","journal-title":"Mater Socio-Medica."},{"issue":"23","key":"10.1016\/j.vaccine.2022.06.060_b0020","first-page":"3611","article-title":"Autoimmune thyroid disease: mechanism, genetics and current knowledge","volume":"18","author":"Dong","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2022.06.060_b0025","first-page":"45","article-title":"Autoimmune Thyroiditis in Childhood","volume":"5","author":"Brown","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol."},{"key":"10.1016\/j.vaccine.2022.06.060_b0030","unstructured":"Franco J.S., Amaya-Amaya J., Anaya J.M. Thyroid disease and autoimmune diseases [Internet]. Autoimmunity: From Bench to Bedside [Internet]. El Rosario University Press; 2013 [cited 2020 Oct 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459466\/."},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.060_b0035","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/INF.0b013e318149dfea","article-title":"Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions","volume":"26","author":"Siegrist","year":"2007","journal-title":"Pediatr Infect Dis J."},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.060_b0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4274\/jcrpe.galenos.2020.2020.0225","article-title":"An Estimation of the Incidence of Thyroiditis Among Girls in Primary Care in Spain","volume":"13","author":"Mart\u00edn-Merino","year":"2021","journal-title":"J Clin Res Pediatr Endocrinol [Internet]."},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.060_b0045","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.vaccine.2019.11.081","article-title":"Human papillomavirus vaccination coverage, policies, and practical implementation across Europe","volume":"38","author":"Nguyen-Huu","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2022.06.060_b0050","unstructured":"Evoluci\u00f3n coberturas de sarampi\u00f3n, rubeola y parotiditis (TV) y virus del papiloma humano (VPH). ESPA\u00d1A 2008-2017 (actualizaci\u00f3n). [Internet]. Ministerio de Sanidad, Consumo y Bienestar Social. Available from: https:\/\/www.sanidad.gob.es\/en\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/coberturas\/docs\/Todas_las_tablas2017.pdf"},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.060_b0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40290-019-00309-9","article-title":"The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval","volume":"33","author":"Mart\u00edn-Merino","year":"2019","journal-title":"Pharm Med."},{"key":"10.1016\/j.vaccine.2022.06.060_b0060","unstructured":"European Medicines Agency. EudraVigilance. European database of suspected adverse drug reaction reports [Internet]. [cited 2021 Mar 22]. Available from: http:\/\/www.adrreports.eu\/en\/index.html."},{"issue":"36","key":"10.1016\/j.vaccine.2022.06.060_b0065","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.vaccine.2017.06.030","article-title":"Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France","volume":"35","author":"Miranda","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2022.06.060_b0070","unstructured":"An observational cohort study to assess the risk of autoimmune diseases in adolescent and young adult women aged 9 to 25 years exposed to Cervarix\u00ae in the United Kingdom [Internet]. 2015 Jun [cited 2017 May 25]. Available from: https:\/\/www.gsk-clinicalstudyregister.com\/files2\/116239-Clinical-Study-Result-Summary.pdf"},{"key":"10.1016\/j.vaccine.2022.06.060_b0075","unstructured":"GlaxoSmithKline Biologicals, SA. Study reports for Study 205639 (EPI-HPV-069 VS MA) \u2018Meta-analysis of the risk of autoimmune thyroiditis diseases, Guillain-Barr\u00e9 Syndrome, and Inflammatory Bowel Disease with Cervarix Vaccination\u2019. Report Amendment 2 Final [Internet]. Available from: http:\/\/www.encepp.eu\/encepp\/openAttachment\/studyResultLatest\/29520;jsessionid=J56mUHwgOm7xpvSrh0Zchy6Xwu8R3gdmjlbe89YWqkUtiAGMz0ln!-850087678."},{"key":"10.1016\/j.vaccine.2022.06.060_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m4931","article-title":"Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study","author":"Yoon","year":"2021","journal-title":"BMJ."},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.060_b0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","article-title":"Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine","volume":"271","author":"Chao","year":"2012","journal-title":"J Intern Med."},{"key":"10.1016\/j.vaccine.2022.06.060_b0090","unstructured":"BIFAP Base de datos para la Investigaci\u00f3n Farmacoepidemiol\u00f3gica en Atenci\u00f3n Primaria [Internet]. [cited 2021 Jan 28]. Available from: http:\/\/bifap.aemps.es\/."},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.060_b0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/pds.4674","article-title":"The recording of human papillomavirus (HPV) vaccination in BIFAP primary care database: A validation study","volume":"28","author":"Mart\u00edn\u2010Merino","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"S3","key":"10.1016\/j.vaccine.2022.06.060_b0100","first-page":"3","article-title":"Determinants of the HPV vaccination among girls attending Spanish primary care settings. Abstrat 4744. ICPE All Access conference abstracts","volume":"29","author":"Castillo-Cano","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.vaccine.2022.06.060_b0105","unstructured":"Ministerio de Sanidad, consumo y Bienestar Social. Porcentaje de poblaci\u00f3n cubierta por el sistema sanitario publico. Encuesta Nacional de Salud [Internet]. Indicadores clave del Sistema Nacional de Salud. 2018 [cited 2021 Oct 28]. Available from: http:\/\/inclasns.msssi.es\/main.html"},{"key":"10.1016\/j.vaccine.2022.06.060_b0110","unstructured":"ICPC-2. International classification of primary care. Second Edition. Oxford: Oxford University Press; 1998."},{"key":"10.1016\/j.vaccine.2022.06.060_b0115","unstructured":"World Health Organization. WHO IRIS: International classification of diseases\u00a0: [9th] ninth revision, basic tabulation list with alphabetic index [Internet]. 1978 [cited 2017 Sep 26]. Available from: http:\/\/www.who.int\/iris\/handle\/10665\/39473"},{"issue":"10","key":"10.1016\/j.vaccine.2022.06.060_b0120","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/pds.5006","article-title":"Base de Datos para la Investigaci\u00f3n Farmacoepidemiol\u00f3gica en Atenci\u00f3n Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain","volume":"29","author":"Maci\u00e1-Mart\u00ednez","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.vaccine.2022.06.060_b0125","unstructured":"Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios. Gobernanza del acceso a los datos de BIFAP (Base de datos para la Investigaci\u00f3n Farmacoepidemiol\u00f3gica en Atenci\u00f3n Primaria). [Internet]. 2021 [cited 2021 Mar 30]. Available from: http:\/\/bifap.aemps.es\/docs\/Gobernanza_acceso_datos_BIFAP_v2_2021.pdf"},{"key":"10.1016\/j.vaccine.2022.06.060_b0130","unstructured":"Castillo-Cano B., Comas-Cuf\u00ed M., Mart\u00edn-Merino E. Handling with vaccine type missing data in a dynamic cohort to assess the link between time-varying vaccination and an autoimmune disease. Abstracts of the 37th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, August 23, 2021. Pharmacoepidemiol Drug Saf. 2021 Aug;30 Suppl 1:236."},{"key":"10.1016\/j.vaccine.2022.06.060_b0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2017.01.005","article-title":"Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance","volume":"79","author":"Grimaldi-Bensouda","year":"2017","journal-title":"J Autoimmun."},{"key":"10.1016\/j.vaccine.2022.06.060_b0140","unstructured":"Collin C. , Miranda S. , Christophe C. , Poidvin A. , De-Boissieu P. , Weill A. , et al. HPV vaccines and risk of thyroid disorders in young girls . Abstract."},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.060_b0145","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1517\/14740338.2015.1073710","article-title":"The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases","volume":"14","author":"Baker","year":"2015","journal-title":"Expert Opin Drug Saf."},{"issue":"9396","key":"10.1016\/j.vaccine.2022.06.060_b0150","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet Lond Engl."},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.060_b0155","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.autrev.2014.01.054","article-title":"On the relationship between human papilloma virus vaccine and autoimmune diseases","volume":"13","author":"Pellegrino","year":"2014","journal-title":"Autoimmun Rev."},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.060_b0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun."},{"key":"10.1016\/j.vaccine.2022.06.060_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects","volume":"47","author":"Perricone","year":"2013","journal-title":"J Autoimmun."},{"issue":"27","key":"10.1016\/j.vaccine.2022.06.060_b0170","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.vaccine.2011.04.046","article-title":"The safety evaluation of adjuvants during vaccine development: the AS04 experience","volume":"29","author":"Gar\u00e7on","year":"2011","journal-title":"Vaccine."},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.060_b0175","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12026-016-8890-y","article-title":"HPV and systemic lupus erythematosus: a mosaic of potential crossreactions","volume":"65","author":"Segal","year":"2017","journal-title":"Immunol Res."},{"key":"10.1016\/j.vaccine.2022.06.060_b0180","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun."},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.060_b0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat Rev Rheumatol."},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.060_b0190","first-page":"450","article-title":"ACTUALIZACI\u00d3N EN MEDICINA DE FAMILIA: Manejo de la patolog\u00eda tiroidea en Atenci\u00f3n Primaria I. Cribado de patolog\u00eda tiroidea","volume":"34","author":"P\u00e9rez Unanua","year":"2008","journal-title":"Hipotiroidismo. Med Fam SEMERGEN."},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.060_b0195","first-page":"1047","article-title":"Thyroiditis: Differential Diagnosis and Management","volume":"61","author":"Slatosky","year":"2000","journal-title":"Am Fam Physician."},{"issue":"03","key":"10.1016\/j.vaccine.2022.06.060_b0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/JLP.JLP_72_17","article-title":"Importance of combined approach of investigations for detection of asymptomatic Hashimoto Thyroiditis in early stage","volume":"10","author":"Saraf","year":"2018","journal-title":"J Lab Physicians."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:53Z","timestamp":1759403753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22008295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22008295"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9\u201318\u00a0years: A time-varying cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}